49
Views
0
CrossRef citations to date
0
Altmetric
Commentary

Pharmacy services during COVID-19 pandemic: experience from a tertiary care teaching hospital in Pakistan

ORCID Icon, , , &
Article: 74 | Received 29 Sep 2020, Accepted 28 Oct 2020, Published online: 04 Dec 2023

References

  • Han Q, Lin Q, Jin S, You L. Recent insights into 2019-nCoV: a brief but comprehensive review. J Infect. 2020. https://doi.org/10.1016/j.jinf.2020.02.010.
  • Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733.
  • Bukhari N, Rasheed H, Nayyer B, et al. Pharmacists at the frontline beating the COVID-19 pandemic. J Pharm Policy Pract. 2020. https://doi.org/10.1186/s40545-020-00210-w.
  • Kirmani S, Saleem A. Impact of COVID-19 pandemic on paediatric services at a referral centre in Pakistan: lessons from a low-income and middle-income country setting. Arch Dis Child. 2020. https://doi.org/10.1136/archdischild-2020-319424.
  • Kalil AC. Treating COVID-19—off-label drug use, compassionate use, and randomized clinical trials during pandemics. JAMA. 2020;323(19):1897–1898.
  • Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420–422.
  • Su H, Yang M, Wan C, Yi L-X, Tang F, Zhu H-Y, et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int. 2020. https://doi.org/10.1016/j.kint.2020.04.003.
  • Gross AE, MacDougall C. Roles of the clinical pharmacist during the COVID-19 pandemic. J Am Coll Clin Pharm. 2020;3(3):564–566.
  • Atif M, Malik I, Mushtaq I, Asghar S. Medicines shortages in Pakistan: a qualitative study to explore current situation, reasons and possible solutions to overcome the barriers. BMJ Open. 2019;9(9):e027028.
  • Gao J, Tian Z, Yang X. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends. 2020. https://doi.org/10.5582/bst.2020.01047.
  • Ford N, Vitoria M, Rangaraj A, Norris SL, Calmy A, Doherty M. Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID-19: initial assessment. J Int AIDS Soc. 2020;23(4):e25489.
  • Zhang W, Zhao Y, Zhang F, Wang Q, Li T, Liu Zet al. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): the experience of clinical immunologists from China. Clin Immunol. 2020. https://doi.org/10.1016/j.clim.2020.108393.
  • Li H, Zheng S, Liu F, Liu W, Zhao R. Fighting against COVID-19: innovative strategies for clinical pharmacists. Res Soc Adm Pharm. 2020. https://doi.org/10.1016/j.sapharm.2020.04.003.
  • Gan WH, Lim JW, David K. Preventing intra-hospital infection and transmission of COVID-19 in healthcare workers. Saf Health Work. 2020. https://doi.org/10.1016/j.shaw.2020.03.001.
  • Murray MD, Shojania KG. Unit-dose drug distribution systems. Making health care safer: a critical analysis of patient safety practices. 2001;101(4):4–9.
  • Ali AA, Azfar AI, Hamad A, Abdul K. Evaluation of medicine return from wards to inpatient pharmacy in tertiary care hospital. Lat Am J Pharm. 2019;38(4):712–718.
  • Wong J, Goh QY, Tan Z, Lie SA, Tay YC, Ng SY, et al. Preparing for a COVID-19 pandemic: a review of operating room outbreak response measures in a large tertiary hospital in Singapore. Can J Anesth. 2020;67:732–745.
  • Zhang H-W, Yu J, Xu H-J, Lei Y, Pu Z-H, Dai W-C, et al. Corona virus international public health emergencies: implications for radiology management. Acad Radiol. 2020. https://doi.org/10.1016/j.acra.2020.02.003.